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When a foreign material or an infectious agent, 
antigen(s), penetrates natural defense barriers and 
gain access into the tissues of a mammalian host, 
specialized cells in the lymphoid tissue recognize 
and incite a response specifically directed against 
the fo reign antigen . This response is biphasic. 
composed of two separate components . One culmi-
nates in the synthesis and secretion . by B-Iym-
phoid cells. of specific antibodies which a re dis -
seminated into the lymph and blood vascular 
systems. where they gain access to and react 
specifically with the antigen(sl. The second phase 
occurs simultaneously with the first and results in 
stimulation and expansion of a clone of reactive 
T-Iymphoid cells which. when fully differentiated. 
can migrate from the lymphoid tissue(s) to the 
antigen and t.here reac t against it. The latter 
reactions have been termed cell-mediated immu-
nit~- (CM II and are primaril~' associated with 
tissue destruction. typified by allograft rejection. 
t.umor i mmunit~· , autoimmunit~·. and , ·a ri ous 
forms of delayed hypersensiti,·i iies . The effector 
cells involved in these important immunologic 
reactions in "i,·o appear to be primari l~· lympho-
cytes and monocytes or macrophag-es. Our under-
standing of the basic mechanismls) that is opera-
ti,·e in t hi_ important group of reactions has co me 
primarilv from recent studies performed b~· numer-
ous im·estig-ators. In ,·itro systems. which appear to 
be models of in vivo situations. ha'·e facilitated 
mo re defined studies and allowed us to dissect 
these Teactions into their various parts. 
eM! reaction, in , 'itro are complex and take 
several forms. One of the earliest indica tio ns of a 
reaction is ··actiyation·· of the lymphocyte. which 
occu rs afte r the immune cell is cultu red with the 
specific ant ig-en . or "normar- cells are cultured 
with anyone of a number of mitogenic agents [1. 
2]. This change is indicated by morpholog-i c and 
biosynthetic transformation of t.he normall~' quies-
cent small lymphocytes into a biosyntheticall~· 
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AbbreviatioM: 
CM I: cell-mediated immunity 
Con-A: concanavalin A -
LIF: leukocyte inhibi ting factor 
LK: Lymphokine 
L T: lymphotoxin 
MIF : migration inhib ition facto r 
M LC: mixed leukocvte culture 
PHA: phytohemaggiutinin 
PMN : polymorphon uclear 
PPD: purified protein derivati,·e 
TF: transfer factor 
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active or t ransformed blast cell . The morphologic 
transformation may occur within the first 24 to 48 
hr. After 36 to 48 hr, certain cells in the activated 
population begin D A synthesis and. later, cell 
division ... Activated" lymphoid cells gain the abil-
ity to express certain effectur functions which can 
be measured in vitro. such as specific or nonspe-
cific cytolysis of ·· target " cells [3.4] and secretion 
into the culture media of a family of soluble 
molecules. which have collectively been termed 
Iymphokines (LK s) [5,6 ]. The amount of informa-
tion available on each of the aforementioned step: 
(a) cellular transformation. (b) D]\;A biosynthesis. 
(c) cvtotoxicitv. and (dl LK secretion. is extensive. 
and ~ach area- has been reviewed . yet the relation-
s hip of these steps, one to anothe r. is still not clear. 
It is not yet clear whether the same cells partici-
pate in each of the above steps or whether a 
composite of man~· separate cell types and reac-
tions is iO\·olved in a progression of Telated events. 
It is ob , ·ious. however. that the cells hold the key to 
ou r understanding of the mechani mIS' operati,·e 
in eVIl. 
The general purpose of thi s re,·iew is to briefly 
discuss salient featu res about the famil~· of soluble 
molecule released by acti,·ated lympho id cells. 
and more specificallv. studies on two of them. 
leukoc~'te inhibiting factor IUF) and lymphotoxin 
(L Tl. and the role t ha t one of them, L T. ma~· play 
in c"tot.oxic CMl reactions. For more detailed 
in for'mation on t he general lopic of LK. one shou Id 
consult any of se,-eral recent fe,'iew articles 16-9]. 
Table I contains an up-to-date list of the spectrum 
of acti"it ies. collectively termed LKs. which have 
been reported to be present in the cell-free super-
natant media obtained from mitogen-stimulated. 
antigen-acti,·a ted. and mixed lymphocyte cultures 
of human and experimental animall~'mphoid cells 
[10]. While the list of individual acti,·ities is exten-
si,-e. they appear to fall into se,·eral g-ene ral cate-
gories dependent upon their effect on secondary 
cell in culture . The first caiegory includes those 
factors which exclusivel~· affecl monoeytes and 
macrophages . The various reported acti,·ities 
include: (a) inhibition of migration. (b) biosyn-
thetic activation. and (c) facto rs whieh cause a 
clumping or aggregation. The second categor~' of 
LKs exert the ir effect upon polymorphonuclear 
(PM]\; ) leukocytes: (a) a facto r(s) which inhibits 
migration. as well as (b) specific chemotactic 
facto rs for eosinophils and neutrophils. A third 
category of actiyities express their effects on vari -
ous type of somatic cells: (8) inhibition of acti,·e 
p rol iferation and DNA synthesis of various somatic 
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TABLE 1. Activities associated with cell-free culture 
medium from mitogen-activated or antigen-activated 
lymphoid cells 
1. Factors active on lymphocytes 
A. Histocompatibility antigen-HA 
B. Autostimulating factor-ASF 
C. Antigen requiring transforming facto r-ARTF 
D. Blastogenic factors - BF 
E. B-cell stimulating factor-BS 
2. Factors active on polymorphonuclear leukocytes 
A. Chemotactic factor for neutrophils-CFN 
B. Chemotactic factor for eosinophils- CFE 
C. Eosinophil stimulation promote r- ESP 
D. Leukocyte inhibition factor-LlF 
3. Factors active on monocytes and macrophages 
A. Migration inhibition factor- MlF 
B. Macrophage (aggregation) clumping factor-MCF 
C. Macrophage activation fact.or-MAF 
D. Macrophage spreading inhibition facto r-MSlF 
E. Migration enhancement factor- MEF 
4. Factors active on non lymp hoid mesenchymal cells 
A. Lymphotoxin- LT 
B. Proliferation inhibition factor-PlF 
C. Colony inhibition facto r- ClF 
5. Miscellaneous factors found in supernatant medium 
A. Skin reactive factor- SRF 
B. Antibodies- Ab 
C. Interferon- lF 
6. Factors extracted from intact lymphoid cells 
A. Lymph node permeability factor-LNPF 
B. Transfer factor- TF 
cell type, and (b) a nonspecific cell toxin. The last 
category of LKs to be considered here are those 
t hat affect lymphocytes themsel ves . These 
include: raj factor (s) which specifically or nonspe-
cifically induces blastogenesis and transformation. 
and (b) those which have helper properties in 
T-cell - B-cell interactions. While the relative con-
centrations of the agent(s ) responsible for the 
activities may vary. dependent upon the culture 
conditions employed. it appears that all activities 
can be secreted into the supernatant media 
obtained from a single activated lymphocyte cul-
ture [6]. There is one exception, transfer factor 
(TF ). which is an intracellular product obtained by 
extracting cytoplasmic components from immune 
lymphocytes [1 1]. 
While no concrete evidence exists at t his time, a 
functional in vivo role for many of these mediators 
would be easy to envision. The activities associa ted 
with the first , second . and fourth categoreis have 
effects which would result in recruitment and 
activation of effector mechanisms and allow other-
wise uninvolved cell types to become participants 
in t.he CMI reaction . The inhibitory activities 
present in the third cat.egory, either cytostatic or 
cytotoxic, would permit the triggered lymphocyte 
itself to be a direct and primary effector cell in the 
CMI reaction. Secreted helper factors for B-cells 
would presumably facilitate the secretion of anti-
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bodies by specific B-lymphocytes. This latter ac-
tivity mayor may not be related to a CMI reaction. 
There are a number of important parameters 
which affect the in vitro synthesis and secretion of 
LKs by activated lymphocytes. While lymphoid 
cells from many animal species, including man, 
secrete them when activated by co-culture with 
antigens, mitogens. or histoincompatible cells, the 
actual levels present in a supernatant may differ 
greatly 15-7]. The cells from certain animal species 
appear to secrete more than others in vitro. 
Whether this effect. is due to inherent differences 
between the capacity of the cells to actively 
secrete LKs in vitro, or simply due to the survival 
or maintenance of the activat.ed cells in tissue cul-
ture is not absolut.ely clear. A second important 
parameter to consider is the tissue(s) from which 
the lymphoid cells are obtained. Lymphoid cells 
derived from man~' diffe rent lymphoid organs have 
been employed. They all appear to be com petent 
to secrete LKs. However, there is some evidence 
that cells removed directly from mouse tbymus 
cannot secrete L T, when they are mitogen stimu-
lated 112.13 J. It also appears that lymphoid cells 
from tissue closest to the local site of subcutaneous 
deposition of antigen in a guinea pig release t.he 
highest levels of migration inhibition facto r (MIF), 
when cultured with t.he specific ant.igen [14]. 
Whether the increased le"els of LK are due to a 
more "immune" or active secreting cell or a higher 
percentage of im'olved responding cells is not 
known; however. both situations may exist. We 
have found that there appears to be some natural 
segregation of mit.ogen-stimulatable. LT secret ing 
cells within human lymphoid tis ·ues. The most 
effective are cells from adenoids. followed by 
lymph nodes. tonsils, then peripheral blood and 
spleen cells . A very important considerat ion is that 
almost any treatment or agent which induces 
lymphocyte activation in vitro measured by DKA 
synthesis or blast transformation, a lso appears to 
induce the release of LKs . As shown in Figure I , 
the level of LT secreted reaches peak values at the 
same dose of mitogen which induces maximum 
D:\T A synthesis . However. these appear to be 
independent events, because {a) LK secretion 
begins early. before Dt\A synthesis. and Ib) if 
DNA synthesis is blocked. L T secret ion is not 
affected. 
LKs are present in the supernatant fraction of 
cultures activated b~' soluble, viral, fungal and 
cellular antigens, mitogens. mixed lymphocyte 
cultures. and in supernatants from certain contin-
uous lymphoid cell lines [9 ]. There are few or no 
data available to indica te whet.her one antigen is 
more competent than another to induce LKs. 
However , there is evidence indicating that mito-
gens. typified by phytohemaglutinin (PHA ) or 
concanavalin A (Con-A) induce high levels of LK. 
The increased levels are presumed to be due to the 
capacity of these agents to activate a higher 
percent of the total secreting cell population than 
that capable of activation by antigens . While the 
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FIG. 1. Relationship observed between DKA synt hesis 
and Iymphot.oxin (L T ) sec ret ion when human lympho-
cytes were cultured in the presence of va rious concentra-
ti ons of concanavali n A. The lymphocytes were cu lt ured 
in MEM conta in ing 590 boiled serum. A unit of L T 
activi ty is defined as the reci procal of the dilution of 
mediu m caus ing destruction of 50.000 larget L-cells in a 
24-hr pe riod . 
mitogen a re termed nonspecifi c. beGau e they 
induce the ac t ivat ion of nonimmune cells. the 
evidence to date ind icates that MIF. released by 
Con-A a nd antigen-activated guinea -pig cells. is 
phys ically the same [5.15 J, and LT released by 
PHA. Con-A. purified protei n derivative (PPD) , 
and mixed leukocyte culture (?-.1LC) ac ti vated 
human cell appears to be physically identica l 
[16- 18J. These obsen'ations which. if true for the 
other LKs, indicate t hat no matter how the lymph-
oid cell is ac tiva ted the pa rticula r LK released ma~' 
be the same molecule. Finall \'. there are. of course. 
various important technical ~onside rations related 
to the in vitro culture techniques. such as the t~'pe 
and amou nt of serum. the numbers of cel ls per ml 
employed . the dosage of acti,-ating agen t (s) u ed. 
all of which must be taken into account to induce 
the "maximum" levels of a pa rt icular LK. 
There is surprisingly little known about the 
pa rt icula r cell type invoked and the event which 
may "regulate" the secretion of LKs. Whil e th e 
evidence is very convincing that the major LKs 
a re lymphocyt.e products. it is not as clear for the 
more peripheral and lesser known acti"it ies. It was 
reported tha t T -cells were required to induce L T 
secret ion in PHA-activated mouse spleen cell cul-
tures. yet it was no! convi nci ngl~- demonstrated 
tha t B-cells could not partic ipate afte r T -cells had 
become acti"ated 11 2 J. Ident ification of the cell 
types and regulatory process(es) im'oked in LK 
secretion is importa nt and an exciti ng a rea about 
whi ch little is known. fo r if L1\:s have a centra l ro le 
in CM f reactions, t he mechanism (s) which con trols 
them regulates the degree and magnitude of the 
response itself. This is one of the most im portant 
areas that requ ires study, for it seems highly 
improbable that upon activation the effector cell 
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would indiscriminately release these highly active 
biologic molecules out into the surrounding tissue 
without some form of regulatory mechanism ( ) 
operative on the sequence. amount. and species of 
molecules released . 
]\0 discussion of LKs is complete without a brief 
considerat ion of some of the physica l properties of 
t his family of molecules. For more detailed infor -
mation, the reader is referred to other review 
a rticles [5 ,6 ]. From Table II, it can be seen that 
the majority of human lymphocyte effector mole-
cules appear to be macromolecula r in character . 
They a re heterogeneous in size; the largest among 
the human lymphocyte effector molecules appears 
to be LT. with a molecular weight of approxi-
mately 90,000 daltons, t he smallest TF a t 10.000 
daltons . Both human and guinea-pig LKs are also 
heterogeneous with regard to their elect rophoreti c 
mobility, and migra te all t he way from fast gamma 
glob ul ins to prealbu mins. when compared to serum 
protein markers 15,6.8.9 ]. Purification and study 
of these molecu les is tedious. because the assavs 
are difficult. and all investigators agree that LKs 
are present in an active supernat ant in very small 
quantities. This is further emphasized b~' t he fact 
that not one LK has yet been ver ified to be purified. 
pri mari ly because the final fractions contain such 
a small amount of material. 
LEl'KOCYTE !\,HIBITORY FACTOR ILIF I 
Human LIF is a soluble product produced by 
mitogen-stimulated or antigen-st imulated lym-
phocytes that inhibits the migration of human 
PM:\, leukocytes but does not in hibit t he migration 
of human or guinea- pig macrophages as does MIF 
[19J. MlF' has an estimated molecular weight of 
23.000 daltons. LIF has an estimated molecula r 
weight of 68,000 daltons . Human LIF has been 
fou nd to migrate with albumin in gel electrophore-
sis. be resistant to neuraminidase. inacti\'ated by 
ch~·motrypsin. be resistant to 56°C fo r 30 min. and 
not inact iva ted by antibodies against Fab or 
huma n serum albumin. 
'\lODEL OF T HE BASIC 1:\ \lTRO SYSTDtS I\, WHICH 
DIRECT A\,D I \'DIRECT LY:-1PHOCYTE·I\,DlT ED 
CYTODESTRl'CTlO\, OCCl 'RS 
Man~' distinct in vit ro systems have been 
devised and studied which may sen -e as models of 
the in vivo cvtodestructive react ions that occur in 
CM! 13.4]. While the results of these studies are 
numerous and di'-erse. they can be grouped into 
three major categories. whi ch are illustrated in 
Figure :2. The first class of react ions is t~-pified by 
the ituat ion where lymphoid cells are obtained 
from experimenta l animals or human pa tients who 
have been im munized wi t h cellula r or t issue anti-
gens. The im mune lymphoid cells are allowed to 
interact with the imm un izing or donor "target 
cells" in culture. The first t ep is physical con tact 
of the aggressor lymphoid ce lls with the a ntigen-
bearing target cells [20,21 J. Thi is a recognit ion 
step. presumably facili ta ted b~' a specific receptor 
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TABLE n. Physical properties of activities associated with hum.an lymphocyte effector molecules 
Effect of Molecular Enz.\'m~ treatment Electro- Molecular Factor phorNic heotinR wei:!:ht Protease Nuclease mubill1Y ~pecies 
Macrophage Stable to 56°G 25.000 Albumin 
inhibition 
Cytotoxic Inact-. 10° at 90,000 Resists Alpha glob. Protein 
SO ± 5°C 
Colony inhibi- Inaet. at 56°G Trypsin Resists Prot-ein (?) 
tion &SO°C ensitive 
Interfe ron Stable at 56°G IS- 20,000 T rypsin Resist-ant Prote in 
sensitive 
Macrophage Heterogeneous 
clumping Alb .-Alpha 
glob. 
Histocompati- Inact. at 56°G Pelleted at Resistant Lipoprotein (?) 
bility Ag I '- 10' x g 
Autostimulat- Inact. 15" at Nondialyzable Resistant 
ing factor 80°C 
Antigen requir- Inact. 30" at 56 °C l'iondialyzable 
ing transform-
ing facto r 
T ransfer fae- Inact. 56°C 10.000 Idia- Resists Resistant Polynucleotide 
tor (I) lyzablel trypsin peptide 
Transfer fac- Inact. 90 °C 150.000 non- Protein lipid 
tor (2) dialyzable carbohydrate 
Chemotactic 25.000 
Steps in 
Contact with AQ Lymphocyte Act ivat ion I CIII de,'ruc'lon 
L Cellular Ags 
.. 
IT~ ce lll 
II. Soluble Ags 
FIG. 2. Schemat ic diagram of tbe various t.ypes of possible mechanisms associated with lymphocyte-mediated 
cytodestructi\,e reactions in vitro. 
on the membrane of the aggressor lymphocyte. 
This poorly understood interaction leads to "acti-
vation" of the lymphocyte biosynthetic processes 
which result in induction of effector function and 
which lead to specific destruction of the target cel l. 
Since this phenomenon requ ires contact of aggres-
sor and target cells , it is termed direct destruction 
13 j. The second class is where lymphoid cells are 
collected from donors who have been immunized 
with soluble macromolecular antigens . This cyto-
toxic reaction in vitro take' two fo rms: (a) co-cul-
ture of the immune lymphoid cell with the antigen 
Nov . 1976 
results in contact and recognition of the ant igen, 
resulting in activation of the ly mphocyte and 
induction of nonspecific destruction of ta rget cells 
at a distance from the aggressor lymphocyte 
[22- 24]. This latter reaction. since it does not 
require physical contact of th e lymphocyte a nd 
target. cell . will be referred to as indirect cytolysis: 
(b) interaction of the immune Iymphocyt.e with 
target cells that ha\'e t he ant igen chemically 
attached to their s urface induces specific trigger-
ing. ly mphocyte ac ti vation. and nonspecific de -
struction of the target cell 125]. l t is not well 
substantiated but generally accepted tha t cell 
destruction in the tirst three categories is mediated 
prima rily by thy mus-dependent cells . however. 
Ol her cell types can parti ci pate 126 j. 
Wh ile these basi c categories of react ions ha \'e 
fundamental differences. they do ha\'e certain 
steps in co mmon . The~' all sha re some form of 
recognit ion reaction ca using activation of th e 
lymphoid cell . and they s hare the act ua l cytotoxic 
s tep. 
It has been determined t hat these reac tions are 
complement independent. requi re "acti\'ated" "ia -
ble lymphoid cells . and. once t ransformed. the 
blast cell is a more effective killer r23.2.5.~ 7]. The 
degree of destruction \'a r ies with time. t he t~' pe of 
target ce ll employed. and the nu m her of effector or 
aggressor lym phoid ce ll s per target cel l [3 J. The 
fi rst step in all of t he aforementi oned react ion. is 
recogni tion . ln an unknown manner. the immun e 
lymphoid cell specifi ca lly recognizes and interacts 
with the ant igen. This reaction presumably is 
in it iated by specific recepto rs on the aggressor cell 
su rface. V,-hether this i, suffic ien t to trigger activa-
tion per se is still unknown. In rhe case of mitogen-
induced C\·to(Ox ic reactions. the mitogen appea rs 
to int.era~ t with the monosaccharide receptors 
present on immune or nonimm une lym phoid cell 
surfaces. Both mitogen and a ntigen induce activa-
t ion . which resu lts in transfo rm ati on of t he nor-
ma lly quiescent h'mphocyte int o t he functional 
effector cell. It has recent ly been determined in in 
vitro s~·stems . emp l o~' ing immune murine lympho-
cytes and mitogen-ac ti\'ated human Iymphoc~·tes . 
t hat the firs t and second steps can occur ver~' 
rapi dly. within t he firs t hour of the interactio n 
between lymphocyte and target cell. and t hese 
have been termed t he lym phocyte dependent steps 
128]. It also a ppea rs tha t the fi nal dest ructj\'e 
phase. termed the Iymphocvte independent s tep. 
does not require the presence of t he \'iable I~' m -
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phocyte. Actual lysis in these systems may occur 
by two basic mechanisms: (a) physical conta ct of 
the lymphocyte with the target cell induces a 
destructive event which continues afte r removal of 
the aggressor cells and results in target cell de-
struction [29]; (b ) activated ly mphocytes deposi t 
L T or L T -like molecules on the target cell surface 
and these actually cau. e dest ruction . 
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